So it’s farewell to 2021 – a year that promised little and delivered less

If 2020 was the year in the waiting-room then 2021 was perhaps the year of the unfulfilled hype.

As predicted, there was little movement in many of the major issues controlling the CBD market – in particular the continued lack of regulatory clarity regarding the use of CBD in ingestible products showed no sign of change.

Across the EU, UK and US, regulators failed to make much headway in creating a pathway to market for CBD ingestible products.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Pablo Sharrock
+34 722 642 678
Email Pablo